Owens & Minor, Inc. (NYSE:OMI) Shares Sold by Dana Investment Advisors Inc.

Dana Investment Advisors Inc. lessened its position in shares of Owens & Minor, Inc. (NYSE:OMI) by 5.4% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 534,420 shares of the company’s stock after selling 30,761 shares during the quarter. Dana Investment Advisors Inc. owned approximately 0.69% of Owens & Minor worth $6,985,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in OMI. Foundry Partners LLC acquired a new stake in Owens & Minor during the third quarter valued at $5,238,000. Charles Schwab Investment Management Inc. grew its position in Owens & Minor by 13.6% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 2,305,043 shares of the company’s stock valued at $30,127,000 after buying an additional 276,807 shares during the period. Algert Global LLC grew its position in Owens & Minor by 189.4% during the third quarter. Algert Global LLC now owns 276,438 shares of the company’s stock valued at $4,337,000 after buying an additional 180,922 shares during the period. Connor Clark & Lunn Investment Management Ltd. grew its position in Owens & Minor by 374.2% during the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 223,074 shares of the company’s stock valued at $3,500,000 after buying an additional 176,029 shares during the period. Finally, JPMorgan Chase & Co. grew its position in Owens & Minor by 68.4% during the third quarter. JPMorgan Chase & Co. now owns 376,830 shares of the company’s stock valued at $5,912,000 after buying an additional 152,999 shares during the period. Institutional investors and hedge funds own 98.04% of the company’s stock.

Insider Activity at Owens & Minor

In related news, major shareholder Coliseum Capital Management, L purchased 354,901 shares of the business’s stock in a transaction that occurred on Monday, March 3rd. The stock was purchased at an average price of $9.19 per share, with a total value of $3,261,540.19. Following the completion of the acquisition, the insider now owns 9,824,599 shares in the company, valued at $90,288,064.81. This trade represents a 3.75 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this link. Insiders own 3.59% of the company’s stock.

Owens & Minor Price Performance

Shares of Owens & Minor stock opened at $9.73 on Thursday. The business has a 50 day simple moving average of $11.32 and a two-hundred day simple moving average of $13.11. Owens & Minor, Inc. has a 12 month low of $6.07 and a 12 month high of $28.35. The stock has a market capitalization of $751.23 million, a P/E ratio of -14.96, a PEG ratio of 0.20 and a beta of 0.61. The company has a debt-to-equity ratio of 2.11, a current ratio of 1.09 and a quick ratio of 0.45.

Owens & Minor (NYSE:OMI) last announced its earnings results on Friday, February 28th. The company reported $0.55 EPS for the quarter, beating analysts’ consensus estimates of $0.53 by $0.02. Owens & Minor had a positive return on equity of 14.60% and a negative net margin of 0.46%. The business had revenue of $2.70 billion during the quarter, compared to analysts’ expectations of $2.68 billion. During the same quarter in the prior year, the firm earned $0.69 earnings per share. The business’s revenue was up 1.5% compared to the same quarter last year. As a group, analysts predict that Owens & Minor, Inc. will post 1.51 EPS for the current fiscal year.

Owens & Minor announced that its board has approved a stock repurchase plan on Friday, February 28th that authorizes the company to repurchase $100.00 million in shares. This repurchase authorization authorizes the company to reacquire up to 13.6% of its shares through open market purchases. Shares repurchase plans are usually an indication that the company’s board believes its shares are undervalued.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on the stock. Robert W. Baird boosted their target price on shares of Owens & Minor from $10.00 to $11.00 and gave the stock a “neutral” rating in a research note on Monday. UBS Group lowered their price objective on Owens & Minor from $25.00 to $13.00 and set a “buy” rating on the stock in a report on Thursday, February 13th. Two analysts have rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat, Owens & Minor has a consensus rating of “Hold” and an average price target of $15.08.

Owens & Minor Company Profile

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.